Company profile: Cambrex
1.1 - Company Overview
Company description
- Provider of end-to-end small molecule drug substance and drug product development and manufacturing, analytical services and testing, IND-enabling services, and process development. Supports research through commercial scale, covering various dosage forms, streamlining IND submissions, and ensuring regulatory compliance and product safety for small molecule therapeutics.
Products and services
- Analytical Services: Cambrex delivers customized analytical programs supporting drugs across the lifecycle, ensuring regulatory compliance and product safety with regulatory-compliant methodologies tailored to lifecycle needs
- Drug Product Development and Manufacturing: Cambrex develops and fabricates small molecule drug products through early development and prepares for scale-up, covering various dosage forms with scale-up-ready approaches for downstream manufacturing
- Drug Substance Development and Manufacturing: Cambrex engineers and produces small molecule drug substances from early development through commercial scale, supplying commercial-scale routes that advance programs seamlessly across the lifecycle
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cambrex
Summit Clinical Research
HQ: United States
Website
- Description: Provider of integrated non-alcoholic steatohepatitis (NASH) clinical research services, including site selection for top-enrolling trial sites and expedited start-up; site-specific pre-screening and enrollment strategies with branded recruitment; key opinion leader guidance and training; education, evidence generation, data dissemination and digital solutions; network site collaboration and support; and a Cirrhosis Advisory Board.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Summit Clinical Research company profile →
Casimir
HQ: United States
Website
- Description: Provider of virtual trials and remote assessments and qualitative research centered on the patient experience, capturing the real-world impact of treatment interventions on patient quality-of-life through smart outcome measures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Casimir company profile →
Evidera
HQ: United States
Website
- Description: Provider of health economics, outcomes research, market access, data analytics, and epidemiology services for life sciences organizations worldwide, offering real-world evidence and data solutions; non-interventional and interventional studies; patient-centered research; evidence synthesis, modeling and communication; and strategic development consulting to support product value demonstration and market access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evidera company profile →
UAS Labs
HQ: United States
Website
- Description: Provider of science-backed probiotic solutions, offering documented strains for gut, immune, and women’s health; co-development of customized formulations, including those based on L. acidophilus DDS-1; and the STRAIN TO SOLUTION process ensuring stability and safety from development to final product. Also provides The Probiotics Institute educational platform and SCIENCE by Chr. Hansen strains supported by human clinical data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UAS Labs company profile →
ProPharma
HQ: United States
Website
- Description: Provider of independent, single-source regulatory, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies; offering RCO custom solutions across the full product lifecycle, tailored MedTech solutions from concept to market, full-service Oncology CRO capabilities, global lifecycle solutions, and Prodigy technology to de-risk decision making and drive value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cambrex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cambrex
2.2 - Growth funds investing in similar companies to Cambrex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cambrex
4.2 - Public trading comparable groups for Cambrex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →